House releases draft of 5-year FDA user fee reauthorization

04/18/2012 | (subscription required)

House Energy and Commerce Committee Republicans' five-year draft reauthorization of the Prescription Drug User Fee Act combines four user fee programs into one measure, creates programs for generic drugs and biosimilars, and encourages development of pediatric drugs.

View Full Article in: (subscription required)